- 41.6k views
Taking Clinical AI to Routine Direct Care: A Successful Framework for Patient Impact
About the Speaker
Prof. Nicholas Peters
Imperial College Professor of Cardiology, Co- Founder, Imperial Connected Care, Onewelback Heart Health, Arpiem Ltd-delivering UK's biggest AI deployment in NHS primary care.
Professor Nicholas Peters leads the UK's largest Al deployment in NHS primary care. He is Professor of Cardiology, Imperial College London; Co-Founder of Imperial Connected Care OneWelbeck Heart Health, and Arpiem Ltd. Professor Peters is a pioneer in the implementation of tech-enabled care pathways, having founded both NHS and commercial ventures that have delivered multiple sustainable, clinically-led healthcare innovations into routine care under his founding leadership of Imperial's Health Impact Lab. He is the visionary behind #go-to-care - the go-to-market framework for health tech that uses a scalable direct-care approach, not just another pilot or demonstration of effectiveness. Real-world implementation using this proven Health Impact framework, addresses the critical contextual systemic and human factors underpinned by essential deep clinical and regulatory expertise. Professor Peters was onetime advisor to Google Health with which he continues to collaborate among other leading academic and commercial entities with the sole mission of impacting population health through advanced technologies. No Impact, No Interest.
Upcoming Case Discussions
Acne: Disorders and Treatment Approaches
Acne is a common dermatological condition caused by clogged pores, excess sebum production, bacterial growth, and inflammation. It can manifest as blackheads, whiteheads, papules, pustules, or cysts, often leading to scarring if untreated. Various factors, including hormonal changes, diet, stress, and genetics, influence its severity. Treatment approaches range from topical and oral medications, such as retinoids, antibiotics, and hormonal therapy, to advanced procedures like chemical peels and laser therapy. A personalized skincare regimen, along with lifestyle modifications, plays a crucial role in managing and preventing acne.
Congenital Uterine Anomalies
Congenital uterine anomalies are structural abnormalities of the uterus resulting from improper fusion, canalization, or resorption of the Müllerian ducts during fetal development. These anomalies include septate, bicornuate, unicornuate, and didelphys uterus, among others. They can be asymptomatic or associated with infertility, recurrent pregnancy loss, preterm birth, or abnormal menstruation. Diagnosis is typically made using imaging modalities like ultrasound, MRI, or hysterosalpingography. Treatment depends on the type and severity of the anomaly, with surgical correction such as hysteroscopic septum resection often indicated in symptomatic cases. Early detection is crucial for optimizing reproductive outcomes and guiding appropriate management strategies.
Management of Postoperative Pain: Best Practices for GP’s
Effective management of postoperative pain is crucial for promoting recovery and preventing complications. General practitioners should start by assessing pain severity using appropriate scales, then tailor the treatment plan based on the patient's medical history and the type of surgery. A combination of pharmacological approaches, such as non-opioid analgesics (e.g., NSAIDs) and opioids when necessary, should be used to minimize pain while reducing the risk of addiction. Multimodal strategies, including physical therapy and non-pharmacological techniques like cold therapy or mindfulness, can further enhance pain relief. Close follow-up is essential to adjust the treatment as needed and ensure the patient's pain is well-controlled.
Diabetes and Stem Cells: What Does the Future Hold?
The future of diabetes treatment may be revolutionized by stem cell research, offering hope for a long-term cure. Scientists are developing stem cell therapies that could regenerate insulin-producing beta cells in the pancreas, potentially restoring natural insulin production in people with type 1 diabetes. Early clinical trials have shown promising results, with some patients reducing or eliminating their need for insulin injections. While challenges like immune rejection and long-term efficacy remain, continued advancements suggest stem cell therapy could significantly change diabetes management in the coming years.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Prof. Nicholas Peters's Talks on Assimilate
- 30th-Mar -2025, TIME : 10:00AM TO 11:00 AM
- 0